Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric J Bernhard

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Cancer Research|February 25, 2010
Modulating tumor vasculature through signaling inhibition to improve cytotoxic therapyAmit Maity, Eric J Bernhard
International Journal of Radiation Biology|November 10, 2009
Cell signalling and radiation survival: the impact of protein phosphatasesJulie Hamilton, Eric J Bernhard
Cancer Biology & Therapy|April 19, 2008
Progress towards the use of HIV protease inhibitors in cancer therapyEric J Bernhard, Thomas B Brunner
Cancer Biology & Therapy|July 3, 2009
Phosphatase inhibition and cell survival after DNA damage induced by radiationJulie Hamilton, Anna M Grawenda, Eric J Bernhard
Cancer Research|December 25, 2002
Tissue-specific induction of p53 targets in vivoPeiwen Fei, Eric J Bernhard, Wafik S El-Deiry
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 19, 2004
Radiation sensitization by inhibition of activated RasThomas B Brunner, Stephen M Hahn, W Gillies McKenna, et al.
Seminars in Oncology|June 13, 2003
Signaling inhibition with radiation in colorectal cancer: clinical trialsW Gillies McKenna, Ruth J Muschel, Anjali Gupta, et al.
International Journal of Radiation Oncology, Biology, Physics|August 4, 2021
Overview and Lessons From the Preclinical Chemoradiotherapy Testing ConsortiumJeffrey C Buchsbaum, C Norman Coleman, Eric J Bernhard, et al.
Oncogene|August 30, 2003
The RAS signal transduction pathway and its role in radiation sensitivityW Gillies McKenna, Ruth J Muschel, Anjali K Gupta, et al.
Seminars in Radiation Oncology|August 14, 2002
Farnesyltransferase inhibitors as radiation sensitizersW Gillies McKenna, Ruth J Muschel, Anjali K Gupta, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Cancer Research|February 25, 2010
Modulating tumor vasculature through signaling inhibition to improve cytotoxic therapyAmit Maity, Eric J Bernhard
International Journal of Radiation Biology|November 10, 2009
Cell signalling and radiation survival: the impact of protein phosphatasesJulie Hamilton, Eric J Bernhard
Cancer Biology & Therapy|April 19, 2008
Progress towards the use of HIV protease inhibitors in cancer therapyEric J Bernhard, Thomas B Brunner
Cancer Biology & Therapy|July 3, 2009
Phosphatase inhibition and cell survival after DNA damage induced by radiationJulie Hamilton, Anna M Grawenda, Eric J Bernhard
Cancer Research|December 25, 2002
Tissue-specific induction of p53 targets in vivoPeiwen Fei, Eric J Bernhard, Wafik S El-Deiry
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 19, 2004
Radiation sensitization by inhibition of activated RasThomas B Brunner, Stephen M Hahn, W Gillies McKenna, et al.
Seminars in Oncology|June 13, 2003
Signaling inhibition with radiation in colorectal cancer: clinical trialsW Gillies McKenna, Ruth J Muschel, Anjali Gupta, et al.
International Journal of Radiation Oncology, Biology, Physics|August 4, 2021
Overview and Lessons From the Preclinical Chemoradiotherapy Testing ConsortiumJeffrey C Buchsbaum, C Norman Coleman, Eric J Bernhard, et al.
Oncogene|August 30, 2003
The RAS signal transduction pathway and its role in radiation sensitivityW Gillies McKenna, Ruth J Muschel, Anjali K Gupta, et al.
Seminars in Radiation Oncology|August 14, 2002
Farnesyltransferase inhibitors as radiation sensitizersW Gillies McKenna, Ruth J Muschel, Anjali K Gupta, et al.
Pageof 5